Teknova unveils new manufacturing facility for high-quality reagents
Located in Hollister, California, US, the modular manufacturing facility recently received ISO 13485:2016 certification for the production of GMP-grade products.
Previously operational for research-grade production, the new facility adds more than 10,000 ft2 of GMP-certified ISO cleanrooms and provides a three-fold increase in overall manufacturing capacity.
According to Teknova, its new location exemplifies the company’s modular manufacturing platform, further enabling the ‘flexible, scalable and consistent’ production of high-quality reagents that it is known for.
With the new facility, bioprocessing and gene therapy companies are now able to work with Teknova across the entire clinical pipeline.
Stephen Gunstream, CEO and president of Teknova, said: “Our team has worked tirelessly over the past two years to build our new GMP-certified production facility here in Hollister and its opening represents a momentous milestone in our company’s evolution."
“We kept hearing from our customers that they wanted a partner who could support them with custom reagent manufacturing as they scale from research, through process development, and into clinical trials, particularly in batch volumes of less than 2,000 liters. We built this facility to do just that – in the city we’ve called home for almost 20 years – and we look forward to leveraging our facility's modular manufacturing capabilities to continue supporting our customers throughout various stages of their lifecycle.”
Michelle Leonard, CEO of the San Benito County Chamber of Commerce, added: “The San Benito County Chamber of Commerce is thrilled to congratulate Teknova on the opening of their latest manufacturing facility in Hollister, California.”
“As a leading employer and long-time partner in the County, we’re incredibly appreciative of the investment they continue to make in Hollister, providing essential jobs to the area, and increasing our visibility as a key location for the biotech and pharmaceutical industry.”
